Europe Market Report for Hyaluronic Acid Viscosupplementation 2017 - MedCore

  • ID: 4327989
  • Report
  • Region: Europe
  • 494 pages
  • iData Research
1 of 4

FEATURED COMPANIES

  • Anika Therapeutics
  • Croma-Pharma
  • Ferring
  • Integra Biologics
  • LCA Pharma
  • Orotech
  • MORE
General Report Contents:
- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
- Market Drivers & Limiters for each chapter segment
- Competitive Analysis for each chapter segment
- Section on recent mergers & acquisitions

Scope: 2013-2023

Single-Injection Products

Single-injection products are the fastest growing products on the market. As per their name, they require only a single-injection per course of treatment. They are less popular in regions like Italy and Germany, where the costs of the three- and five-injection treatments are relatively low.

Two-Injection Products

Two-injection products are the newest products on this market. As per their name, they require only two-injection per course of treatment.

Three-Injection Cycle Products

Three-injection cycle products are administered once per week for three weeks. These products are generally more popular with patients than their five-injection cycle counterparts, mainly because they require fewer visits to a doctor’s office for the administration of the product. However, a number of products can be used in either three- or five-injection treatments.

Five-Injection Cycle Products

Five-injection cycle products are administered once per week for five weeks. The therapeutic effects generally become apparent to the patients near the end of the therapy cycle, and will last for up to six months. Five-injection cycle is particularly popular in countries where there is a monetary incentive per patient visits for doctors. This has the effect of making the five-injection cycle products more popular with doctors, as the profit per course of treatment is higher.

Osteoarthritis is a condition marked by the degeneration of bone joints and cartilage. Patients who suffer from osteoarthritis experience acute joint pain, tenderness, stiffness, creaking, locking of the joints and inflammation. These symptoms are caused by the degeneration of joint cartilage, subchondral bone and synovial fluid, specifically the polysaccharide hyaluronate. Cartilage and synovial fluid are important for absorbing stress and cushioning joints during normal activity. Progressive deterioration of cartilage and an overactive immune response may also lead to muscle atrophy and chronic disability. Hyaluronic acid (HA) is an anionic, nonsulfated glycosaminoglycan that is naturally present in the human body. It is mainly concentrated in fluids in the joints. Its function is to provide cushioning for joints. Individuals who suffer from osteoarthritis are deficient in these fluids. One of the treatment options for these patients is HA viscosupplementation injections.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Anika Therapeutics
  • Croma-Pharma
  • Ferring
  • Integra Biologics
  • LCA Pharma
  • Orotech
  • MORE
Executive Summary
European Orthopedic Biomaterials Market Overview
Competitive Analysis
Market Trends
Market Developments
Markets Included
Key Report Updates
Version History


1. Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

2. Disease Overview
2.1 Basic Anatomy
2.1.1 Osteology and Musculoskeletal System
2.2 Disease Pathology and Disorders
2.2.1 General Diagnostic
2.2.2 Osteoporosis
2.2.3 Osteoarthritis
2.2.4 Indication for Bone Graft Procedure
2.2.5 Indication for Cartilage Repair
2.2.6 Degenerative Disc Disease
2.3 Patient Demographics
2.3.1 General Statistics

3. Product Assessment
3.1 Product Portfolios
3.1.1 Hyaluronic Acid Viscosupplementation
3.2 Regulatory Issues and Recalls
3.2.1 Hyaluronic Acid Viscosupplementation
3.3 Clinical Trials
3.3.1 Hyaluronic Acid Viscosupplementation

4. Country Profiles
4.1 Introduction
4.1.1 Population
4.1.2 GDP Per Capita
4.1.3 Price Index
4.2 Germany
4.3 France
4.4 United Kingdom
4.5 Italy
4.6 Spain
4.7 Benelux
4.8 Scandinavia
4.9 Austria
4.10 Switzerland
4.11 Portugal

5. Hyaluronic Acid Viscosupplementation Market
5.1 Introduction
5.1.1 Benefits of Viscosupplementation
5.1.2 Synovial Fluid
5.1.3 Treatment Types
5.2 Market Overview
5.3 Market Analysis and Forecast
5.3.1 Total Hyaluronic Acid Viscosupplementation Market
5.3.1.1 Single-Injection Market
5.3.1.2 Three-Injection Market
5.3.1.3 Five-Injection Market
5.4 Drivers and Limiters
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 Competitive Market Share Analysis

Abbreviations

Appendix: Company Press Releases

List of Charts:
Chart 1 1: Orthopedic Biomaterials Market by Segment, Europe, 2013 - 2023
Chart 1 2: Orthopedic Biomaterials Market Overview, Europe, 2016 & 2023
Chart 4 1: Country Profile, Germany, 2016
Chart 4 2: Country Profile, France, 2016
Chart 4 3: Country Profile, United Kingdom, 2016
Chart 4 4: Country Profile, Italy, 2016
Chart 4 5: Country Profile, Spain, 2016
Chart 4 6: Country Profile, Benelux, 2016
Chart 4 7: Country Profile, Scandinavia, 2016
Chart 4 8: Country Profile, Austria, 2016
Chart 4 9: Country Profile, Switzerland, 2016
Chart 4 10: Country Profile, Portugal, 2016
Chart 5 1: Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2013 - 2023
Chart 5 2: Hyaluronic Acid Viscosupplementation Market Breakdown, Europe, 2016
Chart 5 3: Hyaluronic Acid Viscosupplementation Market Breakdown, Europe, 2023
Chart 5 4: Total Hyaluronic Acid Viscosupplementation Market, Europe, 2013 - 2023
Chart 5 5: Single-Injection Market, Europe, 2013 - 2023
Chart 5 6: Three-Injection Market, Europe, 2013 - 2023
Chart 5 7: Five-Injection Market, Europe, 2013 - 2023
Chart 5 8: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Europe, 2016

List of Figures:
Figure 1 1: Orthopedic Biomaterials Market Share Ranking by Segment, Europe, 2016
Figure 1 2: Companies Researched in this Report, Europe, 2016
Figure 1 3: Factors Impacting the Orthopedic Biomaterials Market by Segment, Europe
Figure 1 4: Recent Events in the Orthopedic Biomaterials Market, Europe, 2015 - 2016
Figure 1 5: Orthopedic Biomaterials Markets Covered, Europe, 2016 (1 of 2)
Figure 1 6: Orthopedic Biomaterials Markets Covered, Europe, 2016 (2 of 2)
Figure 1 7: Key Report Updates
Figure 1 8: Version History
Figure 3 1: Hyaluronic Acid Viscosupplementationby Products by Company
Figure 3 2: Class 3 Device Recall Euflexxa (1 Sodium Hyaluronate)
Figure 3 3: Trial Comparing Botulin Toxin Versus Hyaluronic Acid by Intra-Articular Injection (Gotox)
Figure 3 4: Trial to Assess the Structural Effect and Long-Term Symptomatic Relief of Intra-Articular Injections of Ha (Viscoa)
Figure 3 5: Platelet-Rich Plasma vs. Hyaluronic Acid for Glenohumeral Osteoarthritis
Figure 3 6: Comparative Assessment of Viscosupplementation With Polynucleotides and Hyaluronic Acid (Pnha1401)
Figure 3 7: to Look at the Characteristics of Synovial Fluid and Cartilage Matrix in Osteoarthritic Knee After Hyaluronic Acid Injection
Figure 3 8: Platelet-Rich Plasma vs Viscosupplementation in the Treatment of Knee Articular Degenerative Pathology (Prp)
Figure 3 9: Platelet-Rich Plasma Intra-Articular Injection in Treating Hemophilic Arthropathy
Figure 3 10: Effectiveness of Two Hyaluronic Acids in Osteoarthritis of the Knee
Figure 5 1: Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2013 - 2023 (€M)
Figure 5 2: Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2013 - 2023 (Us$M)
Figure 5 3: Total Hyaluronic Acid Viscosupplementation Market, Europe, 2013 - 2023
Figure 5 4: Units Sold by Country, Total Hyaluronic Acid Viscosupplementation Market, Europe, 2013 - 2023
Figure 5 5: Average Selling Price by Country, Total Hyaluronic Acid Viscosupplementation Market, Europe, 2013 - 2023 (€)
Figure 5 6: Average Selling Price by Country, Total Hyaluronic Acid Viscosupplementation Market, Europe, 2013 - 2023 (Us$)
Figure 5 7: Market Value by Country, Total Hyaluronic Acid Viscosupplementation Market, Europe, 2013 - 2023 (€M)
Figure 5 8: Market Value by Country, Total Hyaluronic Acid Viscosupplementation Market, Europe, 2013 - 2023 (Us$M)
Figure 5 9: Single-Injection Market, Europe, 2013 - 2023
Figure 5 10: Units Sold by Country, Single-Injection Market, Europe, 2013 - 2023
Figure 5 11: Average Selling Price by Country, Single-Injection Market, Europe, 2013 - 2023 (€)
Figure 5 12: Average Selling Price by Country, Single-Injection Market, Europe, 2013 - 2023 (Us$)
Figure 5 13: Market Value by Country, Single-Injection Market, Europe, 2013 - 2023 (€M)
Figure 5 14: Market Value by Country, Single-Injection Market, Europe, 2013 - 2023 (Us$M)
Figure 5 15: Three-Injection Market, Europe, 2013 - 2023
Figure 5 16: Units Sold by Country, Three-Injection Market, Europe, 2013 - 2023
Figure 5 17: Average Selling Price by Country, Three-Injection Market, Europe, 2013 - 2023 (€)
Figure 5 18: Average Selling Price by Country, Three-Injection Market, Europe, 2013 - 2023 (Us$)
Figure 5 19: Market Value by Country, Three-Injection Market, Europe, 2013 - 2023 (€M)
Figure 5 20: Market Value by Country, Three-Injection Market, Europe, 2013 - 2023 (Us$M)
Figure 5 21: Five-Injection Market, Europe, 2013 - 2023
Figure 5 22: Units Sold by Country, Five-Injection Market, Europe, 2013 - 2023
Figure 5 23: Average Selling Price by Country, Five-Injection Market, Europe, 2013 - 2023 (€)
Figure 5 24: Average Selling Price by Country, Five-Injection Market, Europe, 2013 - 2023 (Us$)
Figure 5 25: Market Value by Country, Five-Injection Market, Europe, 2013 - 2023 (€M)
Figure 5 26: Market Value by Country, Five-Injection Market, Europe, 2013 - 2023 (Us$M)
Figure 5 27: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market, Europe, 2016
Figure 5 28: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Europe, 2016
Figure 7 1: Press Release Summary
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Fidia
  • Medtronic
  • TRB Chemedica
  • Meda Pharma
  • Sanofi Genzyme
  • Depuy Synthes
  • Bioventus
  • Laboratoire Genevrier
  • Recordati
  • Stryker
  • RTI Biologics
  • Croma-Pharma
  • Zimmer Biomet
  • Anika Therapeutics
  • Bioiberica
  • Documedica
  • Ferring
  • Geistlich
  • Integra Biologics
  • Kuros
  • LCA Pharma
  • Orotech
  • Plasmaconcept AG
  • Stella PharmaceuticalsAlphatec Spine
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll